Sylvain Houle
#127,424
Most Influential Person Now
Researcher ORCID ID = 0000-0002-4231-6316
Sylvain Houle's AcademicInfluence.com Rankings
Sylvain Houlecomputer-science Degrees
Computer Science
#5418
World Rank
#5726
Historical Rank
Computational Linguistics
#750
World Rank
#763
Historical Rank
Machine Learning
#1437
World Rank
#1459
Historical Rank
Artificial Intelligence
#1668
World Rank
#1700
Historical Rank
Download Badge
Computer Science
Sylvain Houle's Degrees
- PhD Computer Science Université de Montréal
- Masters Computer Science Université de Montréal
- Bachelors Computer Science Université de Montréal
Similar Degrees You Can Earn
Why Is Sylvain Houle Influential?
(Suggest an Edit or Addition)Sylvain Houle's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands (2007) (1854)
- Hemispheric encoding/retrieval asymmetry in episodic memory: positron emission tomography findings. (1994) (1551)
- Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. (2000) (1003)
- Age-Related Differences in Neural Activity during Memory Encoding and Retrieval: A Positron Emission Tomography Study (1997) (789)
- Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. (2001) (654)
- Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. (2015) (634)
- Neuroanatomical correlates of encoding in episodic memory: levels of processing effect. (1994) (593)
- Novelty and familiarity activations in PET studies of memory encoding and retrieval. (1996) (554)
- Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. (2006) (541)
- Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. (2009) (490)
- Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. (2004) (454)
- Neuroanatomical correlates of retrieval in episodic memory: auditory sentence recognition. (1994) (447)
- 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation. (1998) (362)
- Activation of medial temporal structures during episodic memory retrieval (1996) (361)
- In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET. (2004) (343)
- Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study. (2001) (342)
- General and specific brain regions involved in encoding and retrieval of events: what, where, and when. (1996) (337)
- Functional brain maps of retrieval mode and recovery of episodic information (1995) (309)
- Functional role of the prefrontal cortex in retrieval of memories: a PET study (1995) (307)
- Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres. (2000) (295)
- Novelty encoding networks in the human brain: positron emission tomography data. (1994) (288)
- Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study (2000) (286)
- Age-Related Differences in Neural Activity during Item and Temporal-Order Memory Retrieval: A Positron Emission Tomography Study (2000) (274)
- The seats of reason? An imaging study of deductive and inductive reasoning (1997) (273)
- Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB (2000) (271)
- Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes. (2004) (262)
- Distinct neural correlates of visual long-term memory for spatial location and object identity: a positron emission tomography study in humans. (1995) (257)
- Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm. (2003) (257)
- Functional Neuroanatomy of Recall and Recognition: A PET Study of Episodic Memory (1997) (255)
- Lower dopamine transporter binding potential in striatum during depression (2001) (252)
- Stimulation of the subthalamic nucleus and impulsivity: Release your horses (2009) (247)
- High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study. (1996) (237)
- Increased Stress-Induced Dopamine Release in Psychosis (2012) (234)
- Seasonal variation in human brain serotonin transporter binding. (2008) (225)
- Abnormal intrinsic brain functional network dynamics in Parkinson’s disease (2017) (224)
- Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography. (2005) (224)
- Serotonin 2A receptors and visual hallucinations in Parkinson disease. (2010) (223)
- Globus pallidus stimulation activates the cortical motor system during alleviation of parkinsonian symptoms (1997) (222)
- Novel 5-HTTLPR Allele Associates with Higher Serotonin Transporter Binding in Putamen: A [11C] DASB Positron Emission Tomography Study (2007) (221)
- The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study. (1995) (216)
- Positron Emission Tomography Quantification of [11C]-DASB Binding to the Human Serotonin Transporter: Modeling Strategies (2001) (214)
- Neuroanatomical Correlates of Human Reasoning (1998) (214)
- The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study. (2001) (209)
- Brain Regions Differentially Involved in Remembering What and When: a PET Study (1997) (202)
- Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD (2010) (189)
- Novel Radiotracers for Imaging the Serotonin Transporter by Positron Emission Tomography: Synthesis, Radiosynthesis, and in Vitro and ex Vivo Evaluation of (11)C-Labeled 2-(Phenylthio)araalkylamines. (2000) (186)
- The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride. (2013) (185)
- Radiosynthesis and initial evaluation of [18F]-FEPPA for PET imaging of peripheral benzodiazepine receptors. (2008) (184)
- The role of the left prefrontal cortex in verbal processing: semantic processing or willed action? (1994) (183)
- In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [11C]-(+)-PHNO (2014) (182)
- Radiotracer synthesis from [(11)C]-iodomethane: a remarkably simple captive solvent method. (2000) (179)
- A positron emission tomography study of silent and oral single word reading in stuttering and nonstuttering adults. (2000) (179)
- Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region? (2005) (178)
- The neural correlates of intentional learning of verbal materials: a PET study in humans. (1996) (176)
- Brain serotonin transporter binding in non‐depressed patients with Parkinson's disease (2007) (175)
- Distribution of Monoamine Oxidase Proteins in Human Brain: Implications for Brain Imaging Studies (2013) (171)
- Large Scale Neurocognitive Networks Underlying Episodic Memory (2000) (170)
- Theta burst stimulation‐induced inhibition of dorsolateral prefrontal cortex reveals hemispheric asymmetry in striatal dopamine release during a set‐shifting task – a TMS–[11C]raclopride PET study (2008) (169)
- An admonition when measuring the lipophilicity of radiotracers using counting techniques. (2001) (167)
- Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study. (2018) (167)
- [11C]RTI‐32 PET studies of the dopamine transporter in early dopa‐naive Parkinson's disease (1997) (166)
- A clinical trial of blood and crystalloid cardioplegia. (1984) (166)
- An automated method for the extraction of regional data from PET images (2006) (166)
- Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence. (2009) (166)
- Prefrontal cortex 5-HT2 receptors in depression: an [18F]setoperone PET imaging study. (1999) (164)
- Elevated brain monoamine oxidase A binding in the early postpartum period. (2010) (164)
- Network Analysis of Positron Emission Tomography Regional Cerebral Blood Flow Data: Ensemble Inhibition during Episodic Memory Retrieval (1996) (164)
- Higher Binding of the Dopamine D3 Receptor-Preferring Ligand [11C]-(+)-Propyl-Hexahydro-Naphtho-Oxazin in Methamphetamine Polydrug Users: A Positron Emission Tomography Study (2012) (159)
- Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics. (2004) (156)
- Hepatocellular carcinoma: pilot trial of treatment with Y-90 microspheres. (1989) (156)
- Dissociation of pathways for object and spatial vision: a PET study in humans (1995) (154)
- Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA. (2015) (154)
- Elevated putamen D(2) receptor binding potential in major depression with motor retardation: an [11C]raclopride positron emission tomography study. (2006) (153)
- Elevated serotonin transporter binding in depressed patients with Parkinson's disease: A preliminary PET study with [11C]DASB (2008) (152)
- Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study. (2010) (151)
- In vitro and in vivo characterisation of [11C]-DASB: a probe for in vivo measurements of the serotonin transporter by positron emission tomography. (2002) (150)
- Binding characteristics and sensitivity to endogenous dopamine of [11C]‐(+)‐PHNO, a new agonist radiotracer for imaging the high‐affinity state of D2 receptors in vivo using positron emission tomography (2006) (150)
- Bupropion occupancy of the dopamine transporter is low during clinical treatment (2002) (149)
- Imaging Dopamine D3 Receptors in the Human Brain with Positron Emission Tomography, [11C]PHNO, and a Selective D3 Receptor Antagonist (2010) (149)
- Influence of l-dopa and pramipexole on striatal dopamine transporter in early PD (2001) (148)
- Neuroanatomic correlates of CCK-4-induced panic attacks in healthy humans: a comparison of two time points (1999) (141)
- Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635. (2002) (139)
- Translocator Protein (18 kDa) Polymorphism (rs6971) Explains in-vivo Brain Binding Affinity of the PET Radioligand [18F]-FEPPA (2012) (136)
- Myocardial metabolism and ventricular function following cold potassium cardioplegia. (1985) (133)
- A positron emission tomography study of short- and long-term treatment effects on functional brain activation in adults who stutter. (2003) (132)
- High-Affinity States of Human Brain Dopamine D2/3 Receptors Imaged by the Agonist [11C]-(+)-PHNO (2006) (132)
- The relationship between D2 receptor occupancy and plasma levels on low dose oral haloperidol: a PET study (1997) (126)
- Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: A [11C] FLB-457 and PET study (2012) (122)
- A phase I dose escalation trial of yttrium‐90 microspheres in the treatment of primary hepatocellular carcinoma (1992) (119)
- Inflammation in the Neurocircuitry of Obsessive-Compulsive Disorder (2017) (113)
- Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment. (2014) (113)
- Functional neuroimaging of cerebellar activation during single word reading and verb generation in stuttering and nonstuttering adults (2001) (111)
- Networks of domain-specific and general regions involved in episodic memory for spatial location and object identity (1998) (111)
- First Human Evidence of d-Amphetamine Induced Displacement of a D2/3 Agonist Radioligand: A [11C]-(+)-PHNO Positron Emission Tomography Study (2008) (108)
- Novel radiotracers for imaging the serotonin transporter by positron emission tomography: synthesis, radiosynthesis, and in vitro and ex vivo evaluation of (11)C-labeled 2-(phenylthio)araalkylamines. (2000) (108)
- Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [18F]FEPPA. (2017) (106)
- In-vivo imaging of grey and white matter neuroinflammation in Alzheimer’s disease: a positron emission tomography study with a novel radioligand, [18F]-FEPPA (2015) (103)
- Cerebral blood flow changes induced by pedunculopontine nucleus stimulation in patients with advanced Parkinson's disease: A [15O] H2O PET study (2009) (103)
- Heightened D3 Dopamine Receptor Levels in Cocaine Dependence and Contributions to the Addiction Behavioral Phenotype: A Positron Emission Tomography Study with [11C]-(+)-PHNO (2014) (99)
- Extrastriatal dopaminergic dysfunction in tourette syndrome (2010) (99)
- Quantitation of Translocator Protein Binding in Human Brain with the Novel Radioligand [18F]-FEPPA and Positron Emission Tomography (2011) (99)
- Increased Vesicular Monoamine Transporter Binding during Early Abstinence In Human Methamphetamine Users: Is VMAT2 a Stable Dopamine Neuron Biomarker? (2008) (96)
- Effects of Tryptophan Depletion on the Serotonin Transporter in Healthy Humans (2005) (96)
- Serotonin 5-HT2 receptors in schizophrenia: a PET study using [18F]setoperone in neuroleptic-naive patients and normal subjects. (1999) (96)
- PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: implications for the therapeutics of schizophrenia. (1997) (94)
- Positron Emission Tomography Quantification of [11C]-Harmine Binding to Monoamine Oxidase-A in the Human Brain (2006) (94)
- A rapid one-step radiosynthesis of the β-amyloid imaging radiotracer N-methyl-[11C]2-(4′-methylaminophenyl)-6-hydroxybenzothiazole ([11C]-6-OH-BTA-1) (2004) (94)
- Positron Emission Tomography Quantification of [11C]-(+)-PHNO Binding in the Human Brain (2007) (93)
- The effect of antipsychotics on the high-affinity state of D2 and D3 receptors: a positron emission tomography study With [11C]-(+)-PHNO. (2009) (93)
- Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease. (2009) (92)
- Imaging Striatal Microglial Activation in Patients with Parkinson’s Disease (2015) (92)
- Synthesis and in vivo evaluation of novel radiotracers for the in vivo imaging of the norepinephrine transporter. (2003) (91)
- Cognitive Subtractions May Not Add Up: The Interaction between Semantic Processing and Response Mode (1997) (89)
- Investing in the Future: Stimulation of the Medial Prefrontal Cortex Reduces Discounting of Delayed Rewards (2015) (88)
- Microglial activation in Parkinson’s disease using [18F]-FEPPA (2017) (85)
- Salience network and parahippocampal dopamine dysfunction in memory‐impaired Parkinson disease (2015) (83)
- Effects of antipsychotics on D3 receptors: A clinical PET study in first episode antipsychotic naive patients with schizophrenia using [11C]-(+)-PHNO (2011) (80)
- Kinetic Modeling of 11C-SB207145 Binding to 5-HT4 Receptors in the Human Brain In Vivo (2009) (79)
- [11C]‐DASB, a tool for in vivo measurement of SSRI‐induced occupancy of the serotonin transporter: PET characterization and evaluation in cats (2003) (78)
- Stress-Induced Dopamine Response in Subjects at Clinical High Risk for Schizophrenia with and without Concurrent Cannabis Use (2014) (78)
- D2-Receptor Upregulation is Dependent upon Temporal Course of D2-Occupancy: A Longitudinal [11C]-Raclopride PET Study in Cats (2009) (77)
- Neural correlates of semantic associative encoding in episodic memory. (2000) (77)
- Stimulation of the Subthalamic Nucleus in Parkinson’s Disease Does Not Produce Striatal Dopamine Release (2003) (76)
- Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography (2007) (75)
- Stimulation of the Pre-SMA Influences Cerebral Blood Flow in Frontal Areas Involved with Inhibitory Control of Action (2013) (75)
- Relationship of Monoamine Oxidase-A Distribution Volume to Postpartum Depression and Postpartum Crying (2015) (75)
- Kinetic Modeling of the Monoamine Oxidase B Radioligand [11C]SL25.1188 in Human Brain with High-Resolution Positron Emission Tomography (2014) (74)
- Dopamine‐agonists and impulsivity in Parkinson's disease: Impulsive choices vs. impulsive actions (2014) (74)
- Neuroinflammation in healthy aging: A PET study using a novel Translocator Protein 18kDa (TSPO) radioligand, [18F]-FEPPA (2014) (73)
- Synthesis and application of isocyanates radiolabeled with carbon-11. (2011) (71)
- Effect of continuous theta burst stimulation of the right dorsolateral prefrontal cortex on cerebral blood flow changes during decision making (2012) (71)
- Benign hereditary chorea: Clinical, genetic, and pathological findings (2003) (71)
- Radiosynthesis of carbon‐11 labelled N‐methyl‐2‐(arylthio)benzylamines: potential radiotracers for the serotonin reuptake receptor (1999) (71)
- [11C]CURB: Evaluation of a novel radiotracer for imaging fatty acid amide hydrolase by positron emission tomography. (2011) (70)
- Blockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925. (2010) (66)
- In vivo evaluation of [11C]- and [18F]-labelled cocaine analogues as potential dopamine transporter ligands for positron emission tomography. (1996) (64)
- Oral D‐amphetamine causes prolonged displacement of [11C]raclopride as measured by PET (2004) (64)
- Monoamine oxidase A binding in the prefrontal and anterior cingulate cortices during acute withdrawal from heavy cigarette smoking. (2011) (63)
- Increased dopamine release in the right anterior cingulate cortex during the performance of a sorting task: A [11C]FLB 457 PET study (2009) (63)
- Effects of self-generated sad mood on regional cerebral activity: a PET study in normal subjects. (1996) (62)
- Mapping Human Brain Fatty Acid Amide Hydrolase Activity with PET (2013) (62)
- Heightened Dopaminergic Response to Amphetamine at the D3 Dopamine Receptor in Methamphetamine Users (2016) (61)
- Radiosynthesis of [11C]SL25.1188 via [11C]CO2 fixation for imaging monoamine oxidase B (2011) (60)
- Activation of the anterior cingulate cortex by thalamic stimulation in patients with chronic pain: a positron emission tomography study. (2000) (60)
- Monoamine Oxidase B Total Distribution Volume in the Prefrontal Cortex of Major Depressive Disorder: An [11C]SL25.1188 Positron Emission Tomography Study. (2019) (60)
- Elevated Striatal Dopamine Function in Immigrants and Their Children: A Risk Mechanism for Psychosis (2016) (59)
- Functional network differences in schizophrenia: a rCBF study of semantic processing (1998) (59)
- [11C]‐(+)‐PHNO PET imaging of dopamine D2/3 receptors in Parkinson's disease with impulse control disorders (2015) (59)
- Activation of the anterior cingulate cortex by thalamic stimulation in patients with chronic pain: a positron emission tomography study (2000) (59)
- Serotonin2A receptor binding potential in people with aggressive and violent behaviour. (2008) (58)
- Prefrontal dopaminergic receptor abnormalities and executive functions in Parkinson's disease (2013) (55)
- Synthesis and ex vivo evaluation of carbon-11 labelled N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea ([11C]AR-A014418): a radiolabelled glycogen synthase kinase-3beta specific inhibitor for PET studies. (2005) (55)
- Greater monoamine oxidase a binding in perimenopausal age as measured with carbon 11-labeled harmine positron emission tomography. (2014) (55)
- The Fatty Acid Amide Hydrolase C385A Variant Affects Brain Binding of the Positron Emission Tomography Tracer [11C]CURB (2015) (54)
- Lower Monoamine Oxidase-A Total Distribution Volume in Impulsive and Violent Male Offenders with Antisocial Personality Disorder and High Psychopathic Traits: An [11C] Harmine Positron Emission Tomography Study (2015) (54)
- Elevation of Dopamine Induced by Cigarette Smoking: Novel Insights from a [11C]-(+)-PHNO PET Study in Humans (2014) (52)
- Positron emission tomography imaging of tau pathology in progressive supranuclear palsy (2017) (52)
- Imaging cAMP-specific phosphodiesterase-4 in human brain with R-[11C]rolipram and positron emission tomography (2002) (52)
- Radiolabeled Small Molecule Protein Kinase Inhibitors for Imaging with PET or SPECT (2010) (51)
- The relationship between subjective well-being and dopamine D2 receptors in patients treated with a dopamine partial agonist and full antagonist antipsychotics. (2009) (50)
- Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John's wort: an [11C]-harmine PET study. (2011) (50)
- Contributions of the mesial frontal cortex to the premovement potentials associated with intermittent hand movements in humans (1996) (50)
- Direct fixation of [(11)C]-CO(2) by amines: formation of [(11)C-carbonyl]-methylcarbamates. (2010) (50)
- Elevated Monoamine Oxidase A Binding During Major Depressive Episodes Is Associated with Greater Severity and Reversed Neurovegetative Symptoms (2014) (49)
- Right ventricular function: a comparison between blood and crystalloid cardioplegia. (1987) (48)
- Modulation of cortical neuronal activity by a serotonergic agent: a PET study in humans (1994) (48)
- Radiosynthesis and Characterization of 11C-GSK215083 as a PET Radioligand for the 5-HT6 Receptor (2012) (48)
- A positron emission tomography study of 5-hydroxytryptamine-1A receptors in Alzheimer disease. (2007) (47)
- Dopaminergic activity in depressed smokers: A positron emission tomography study (2009) (47)
- Relationship of monoamine oxidase A binding to adaptive and maladaptive personality traits (2010) (47)
- Dopamine Response to Psychosocial Stress in Chronic Cannabis Users: A PET Study With [11C]-(+)-PHNO (2013) (47)
- Dopamine modulating drugs influence striatal (+)‐[11C]DTBZ binding in rats: VMAT2 binding is sensitive to changes in vesicular dopamine concentration (2008) (47)
- Dopamine depletion results in increased neostriatal D2, but not D1, receptor binding in humans (2002) (46)
- Tryptophan depletion and serotonin loss in selective serotonin reuptake inhibitor–treated depression: An [18F] MPPF positron emission tomography study (2004) (45)
- Imaging changes associated with cognitive abnormalities in Parkinson’s disease (2015) (45)
- Measuring Cigarette Smoking-Induced Cortical Dopamine Release: A [11C]FLB-457 PET Study (2015) (44)
- Cyproheptadine: a potent in vivo serotonin antagonist. (1997) (44)
- Disrupted Nodal and Hub Organization Account for Brain Network Abnormalities in Parkinson’s Disease (2016) (43)
- Imaging Microglial Activation in Individuals at Clinical High Risk for Psychosis: an In Vivo PET Study with [18F]FEPPA (2017) (43)
- Amphetamine pretreatment induces a change in both D2-Receptor density and apparent affinity: a [11C]raclopride positron emission tomography study in cats (2004) (43)
- D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia (2016) (42)
- Nuclear Cardiac Imaging: Principles and Applications (1987) (41)
- Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [11C]CURB (2016) (41)
- Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive task. (2013) (41)
- Increased left posterior parietal–temporal cortex activation after d-fenfluramine in women with panic disorder (2000) (40)
- Synthesis of two radiofluorinated cocaine analogues using distilled 2-[18F]fluoroethyl bromide. (1995) (39)
- Persistent ventricular adaptations in postoperative coarctation of the aorta. (1986) (39)
- A comparison of nitroglycerin and nitroprusside: I. Treatment of postoperative hypertension. (1985) (39)
- Neuromodulation of frontal and temporal cortex by intravenous d-fenfluramine: an [15O]H2O PET study in humans (1996) (39)
- The D2 Receptor Occupancy Profile of Loxapine Determined Using PET (1996) (38)
- Radiosynthesis and Evaluation of [11C-Carbonyl]-Labeled Carbamates as Fatty Acid Amide Hydrolase Radiotracers for Positron Emission Tomography (2012) (38)
- Development of new radiopharmaceuticals for imaging monoamine oxidase B. (2011) (38)
- Characterization of r-[11C]rolipram for PET imaging of phosphodieterase-4: in vivo binding, metabolism, and dosimetry studies in rats. (2001) (37)
- Task-Independent Effect of Time on rCBF (1998) (37)
- Classics in Neuroimaging: Development of PET Tracers for Imaging Monoamine Oxidases. (2019) (36)
- Convergence of neural systems processing stimulus associations and coordinating motor responses. (1998) (35)
- Effect of perioperative platelet inhibition on postcarotid endarterectomy mural thrombus formation. Results of a prospective randomized controlled trial using aspirin and dipyridamole in humans. (1985) (35)
- Noradrenergic dysfunction in the prefrontal cortex in depression: an [15O] H2O PET study of the neuromodulatory effects of clonidine (2001) (35)
- Increased Seasonal Variation in Serotonin Transporter Binding in Seasonal Affective Disorder (2016) (35)
- Serotonin-1A receptors in frontotemporal dementia compared with controls (2007) (35)
- Properties and Stability of Diamond-like Carbon Films Related to Bonded and Unbonded Hydrogen (1993) (35)
- Contribution of insula in Parkinson's disease: A quantitative meta‐analysis study (2016) (34)
- Convergent Effects of Acute Stress and Glucocorticoid Exposure upon MAO-A in Humans (2012) (34)
- Reliability of a simple non-invasive method for the evaluation of 5-HT2 receptors using [18F]-setoperone PET imaging. (1997) (33)
- Derivatives of WAY 100635 as potential imaging agents for 5-HT1A receptors: syntheses, radiosyntheses, and in vitro and in vivo evaluation. (1998) (33)
- Utility of commercial radiosynthetic modules in captive solvent [11C]‐methylation reactions (2009) (33)
- Activation of specific cortical regions by apomorphine: an [15O]H2O PET study in humans (1994) (33)
- Impaired Prefrontal Cortical Dopamine Release in Schizophrenia During a Cognitive Task: A [11C]FLB 457 Positron Emission Tomography Study (2018) (33)
- Elevated Monoamine Oxidase-A Distribution Volume in Borderline Personality Disorder Is Associated With Severity Across Mood Symptoms, Suicidality, and Cognition (2016) (32)
- Imaging the 5-HT(1A) receptors with PET: WAY-100635 and analogues. (2000) (32)
- [18F]AV-1451 binding to neuromelanin in the substantia nigra in PD and PSP (2018) (31)
- Imaging of cAMP‐specific phosphodiesterase‐IV: Comparison of [11C]Rolipram and [11C]Ro 20–1724 in rats (1999) (31)
- Serotonin transporter binding is reduced in seasonal affective disorder following light therapy (2016) (31)
- Radiosynthesis and ex vivo evaluation of [(11)C-carbonyl]carbamate- and urea-based monoacylglycerol lipase inhibitors. (2014) (31)
- Estimating Endogenous Dopamine Levels at D2 and D3 Receptors in Humans using the Agonist Radiotracer [11C]-(+)-PHNO (2014) (30)
- In vitro stability of EDTA and DTPA immunoconjugates of monoclonal antibody 2G3 labeled with indium-111. (1992) (30)
- In Vivo Imaging of Translocator Protein in Long-term Cannabis Users. (2019) (30)
- Optimized count-based scintigraphic left ventricular volume measurement. (1985) (29)
- Towards the preparation of radiolabeled 1-aryl-3-benzyl ureas: Radiosynthesis of [(11)C-carbonyl] AR-A014418 by [(11)C]CO(2) fixation. (2012) (29)
- Translocator Protein Distribution Volume Predicts Reduction of Symptoms During Open-Label Trial of Celecoxib in Major Depressive Disorder (2020) (29)
- Blocking of Fatty Acid Amide Hydrolase Activity with PF-04457845 in Human Brain: A Positron Emission Tomography Study with the Novel Radioligand [11C]CURB (2015) (28)
- Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors (2015) (28)
- Synthesis and PET imaging studies of [18F]2-fluoroquinolin-8-ol ([18F]CABS13) in transgenic mouse models of Alzheimer's disease (2012) (28)
- Imaging microglial activation and amyloid burden in amnestic mild cognitive impairment (2017) (27)
- Quantitative validation of an intracerebral β‐sensitive microprobe system to determine in vivo drug‐induced receptor occupancy using [11C]raclopride in rats (2004) (27)
- Flow studies in a rigid model of an aorto-renal junction. A case for high shear as a cause of the localization of sudanophilic lesions in rabbits. (1981) (27)
- Fatigue in Parkinson's disease: The contribution of cerebral metabolic changes (2017) (27)
- Cortical stress regulation is disrupted in schizophrenia but not in clinical high risk for psychosis (2018) (26)
- Synthesis and preclinical evaluation of [11C-carbonyl]PF-04457845 for neuroimaging of fatty acid amide hydrolase. (2013) (26)
- Facile radiolabelling and purification of 2β‐[O‐11CH3]‐carbomethoxy‐3β‐aryltropanes: Radiotracers for the dopamine transporter (1994) (26)
- Dopamine response to psychosocial stress in humans and its relationship to individual differences in personality traits. (2012) (26)
- [18F]fluoroalkyl analogues of the potent 5-HT1A antagonist WAY 100635: radiosyntheses and in vivo evaluation. (1996) (26)
- Greater Monoamine Oxidase A Binding in Alcohol Dependence (2014) (26)
- Dynamic, adaptive changes in MAO-A binding after alterations in substrate availability: an in vivo [11C]-harmine positron emission tomography study (2011) (25)
- Light therapy and serotonin transporter binding in the anterior cingulate and prefrontal cortex (2015) (25)
- Occupancy of Dopamine D3 and D2 Receptors by Buspirone: A [11C]-(+)-PHNO PET Study in Humans (2016) (25)
- Development and characterization of a promising fluorine-18 labelled radiopharmaceutical for in vivo imaging of fatty acid amide hydrolase. (2013) (25)
- Distribution of Vesicular Monoamine Transporter 2 Protein in Human Brain: Implications for Brain Imaging Studies (2011) (25)
- Effects of aging on 5‐HT2AR binding: a HRRT PET study with and without partial volume corrections (2011) (25)
- Quantification of translocator protein ( 18 kDa) in the human brain with PET and a novel radioligand, [18F]-FEPPA (2010) (24)
- In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]‐(+)‐PHNO in rats using an intracerebral beta‐sensitive system (2006) (24)
- Nigral Stress-Induced Dopamine Release in Clinical High Risk and Antipsychotic-Naïve Schizophrenia (2017) (24)
- Development of new carbon-11 labelled radiotracers for imaging GABAA- and GABAB-benzodiazepine receptors. (2012) (24)
- Is desire for social relationships mediated by the serotonergic system in the prefrontal cortex? An [18F]setoperone PET study (2010) (23)
- Side Effects Profile in Humans of 11C-(+)-PHNO, a Dopamine D2/3 Agonist Ligand for PET (2010) (23)
- Dopamine depletion results in increased neostriatal D2 receptor binding in humans (2002) (23)
- GABA levels and TSPO expression in people at clinical high risk for psychosis and healthy volunteers: a PET-MRS study. (2019) (22)
- Syntheses and in vitro evaluation of fluorinated naphthoxazines as dopamine D2/D3 receptor agonists: radiosynthesis, ex vivo biodistribution and autoradiography of [(18)F]F-PHNO. (2007) (22)
- Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia (2011) (22)
- Replicating predictive serum correlates of greater translocator protein distribution volume in brain (2019) (21)
- Association of ventral striatum monoamine oxidase-A binding and functional connectivity in antisocial personality disorder with high impulsivity: A positron emission tomography and functional magnetic resonance imaging study (2016) (21)
- Whole Body Biodistribution and Radiation Dosimetry in Humans of a New PET Ligand, [18F]-FEPPA, to Image Translocator Protein (18 kDa) (2013) (21)
- Lack of Age-Dependent Decrease in Dopamine D3 Receptor Availability: A [11C]-(+)-PHNO and [11C]-Raclopride Positron Emission Tomography Study (2015) (21)
- Evaluation of a novel radiotracer for positron emission tomography imaging of reactive oxygen species in the central nervous system. (2017) (20)
- Feasibility study of TSPO quantification with [18F]FEPPA using population-based input function (2017) (20)
- Synthesis and preliminary biological evaluations of [18F]-1-deoxy-1-fluoro-scyllo-inositol. (2009) (20)
- Human Kinetic Modeling of the 5HT6 PET Radioligand 11C-GSK215083 and Its Utility for Determining Occupancy at Both 5HT6 and 5HT2A Receptors by SB742457 as a Potential Therapeutic Mechanism of Action in Alzheimer Disease (2015) (19)
- Syntheses of the phosphodiesterase-4 inhibitors [11C]Ro 20-1724, R-, R/S- and S-[11C]rolipram (2001) (19)
- Decreased binding of the D-3 dopamine receptor-preferring ligand [C-11]-()-PHNO in drug-nave Parkinsons disease (2009) (19)
- Repeatability of estimates of left-ventricular volume from blood-pool counts: concise communication. (1983) (19)
- Special considerations in the pediatric use of radionuclides for kidney studies. (1982) (19)
- A study of vestibular schwannomas using positron emission tomography and monoclonal antibody Ki-67. (1998) (19)
- Influence of a low dose of amphetamine on vesicular monoamine transporter binding: A PET (+)[11C]DTBZ study in humans (2010) (19)
- Quantitative imaging of neuroinflammation in human white matter: A positron emission tomography study with translocator protein 18 kDa radioligand, [18F]‐FEPPA (2014) (19)
- Rapid Recovery of Vesicular Dopamine Levels in Methamphetamine Users in Early Abstinence (2016) (18)
- Elevated fatty acid amide hydrolase in the prefrontal cortex of borderline personality disorder: a [11C]CURB positron emission tomography study (2020) (18)
- Lower brain fatty acid amide hydrolase in treatment-seeking patients with alcohol use disorder: a positron emission tomography study with [C-11]CURB (2020) (18)
- [18F]Fluoroamines via ring-opening of N-Cbz-2-methylaziridine with [18F]-fluoride (2009) (17)
- An improved radiosynthesis of the muscarinic M2 radiopharmaceutical, [18F]FP-TZTP. (2009) (17)
- Imaging 5‐HT1A receptors with positron emission tomography: Initial human studies with [11C]CPC‐222 (1997) (17)
- The Interaction Between Neuroinflammation and β-Amyloid in Cognitive Decline in Parkinson’s Disease (2019) (17)
- Interaction between TSPO—a neuroimmune marker—and redox status in clinical high risk for psychosis: a PET–MRS study (2018) (17)
- Regioselective ring opening of 2-methylaziridine derivatives with 18F- and 19F-fluoride (2011) (16)
- Radiosynthesis and ex vivo evaluation of [(18)F]-(S)-3-(6-(3-fluoropropoxy)benzo[d]isoxazol-3-yl)-5-(methoxymethyl)oxazolidin-2-one for imaging MAO-B with PET. (2015) (16)
- Solid-phase radiosynthesis of [11C]WAY 100635 (1996) (16)
- Imaging Brain Fatty Acid Amide Hydrolase in Untreated Patients With Psychosis (2020) (16)
- Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice. (2011) (15)
- Motor Synchronization to Rhythmic Auditory Stimulation (RAS) Attenuates Dopaminergic Responses in Ventral Striatum in Young Healthy Adults: [11C]-(+)-PHNO PET Study (2019) (15)
- The Relationship Between Serotonin‐2A Receptor and Cognitive Functions in Nondemented Parkinson's Disease Patients with Visual Hallucinations (2017) (15)
- Increased dopamine release in the right anterior cingulate cortex during the performance of a sorting task: a [11C]FLB 457 PET study (2009) (15)
- Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users : Imaging With the Novel Radiotracer [ 11 C ] CURB (2016) (14)
- Stimulation of the Subthalamic Nucleus in Parkinson's Disease Does Not Produce Striatal Dopamine Release. (2005) (14)
- Late postoperative ventricular function after blood and crystalloid cardioplegia. (1986) (14)
- Similar striatal D2/D3 dopamine receptor availability in adults with Tourette syndrome compared with healthy controls: A [11C]‐(+)‐PHNO and [11C]raclopride positron emission tomography imaging study (2015) (14)
- Whole-Body Radiation Dosimetry of 11C-Carbonyl-URB694: A PET Tracer for Fatty Acid Amide Hydrolase (2014) (14)
- Test-retest variability of high resolution positron emission tomography (PET) imaging of cortical serotonin (5HT2A) receptors in older, healthy adults (2009) (14)
- Dopamine D2/3 receptor availability in the striatum of antipsychotic-free older patients with schizophrenia—A [11C]-raclopride PET study (2015) (14)
- Effect of acute antipsychotic administration on dopamine synthesis in rodents and human subjects using 6‐[18F]‐L‐m‐tyrosine (2004) (13)
- Interaction of APOE4 alleles and PET tau imaging in former contact sport athletes (2020) (13)
- Positron-emission tomography imaging of the TSPO with [(18)F]FEPPA in a preclinical breast cancer model. (2013) (13)
- Voxel-Based Imaging of Translocator Protein 18Kda (TSPO) in High-Resolution PET (2013) (13)
- Synthesis and autoradiographic localization of the dopamine D-1 agonists [11C]SKF 75670 and [11C]SKF 82957 as potential PET radioligands. (1996) (13)
- TSPO expression and brain structure in the psychosis spectrum (2018) (13)
- Single-Photon Emission Computed Tomography and Positron Emission Tomography Studies of Antisocial Personality Disorder and Aggression: a Targeted Review (2019) (12)
- Fluorodeoxyglucose positron emission tomography in semantic dementia after 6 months of memantine: an open‐label pilot study (2013) (12)
- Dopamine D1 agonist R-[11C]SKF 82957: synthesis and in vivo characterization in rats. (1999) (12)
- Fatty acid amide hydrolase is lower in young cannabis users (2020) (12)
- Corticotropin-releasing hormone and dopamine release in healthy individuals (2017) (12)
- Occupancy of dopamine D2 and D3 receptors by a novel D3 partial agonist BP1.4979: a [11C]-(+)-PHNO PET study in humans (2018) (12)
- The statistical power of [15O]‐water PET activation studies of cognitive processes (1995) (12)
- Analogues of WAY 100635 as radiotracers for in vivo imaging of 5‐HT1A receptors (1999) (12)
- Lower amygdala fatty acid amide hydrolase in violent offenders with antisocial personality disorder: an [11C]CURB positron emission tomography study (2021) (11)
- Presentation of Smoking-Associated Cues Does Not Elicit Dopamine Release after One-Hour Smoking Abstinence: A [11C]-(+)-PHNO PET Study (2013) (11)
- Amyloid deposition in semantic dementia: a positron emission tomography study (2016) (11)
- Stress‐induced cortical dopamine response is altered in subjects at clinical high risk for psychosis using cannabis (2020) (10)
- Rationally designed PKA inhibitors for positron emission tomography: Synthesis and cerebral biodistribution of N-(2-(4-bromocinnamylamino)ethyl)-N-[11C]methyl-isoquinoline-5-sulfonamide. (2008) (10)
- Image Derived Input Function for [18F]-FEPPA: Application to Quantify Translocator Protein (18 kDa) in the Human Brain (2014) (10)
- In vivo binding of [11C]SKF 75670 and [11C]SKF 82957 in rat brain: two dopamine D-1 receptor agonist ligands. (1996) (10)
- Network Patterns of Beta-Amyloid Deposition in Parkinson’s Disease (2019) (10)
- Inhibition of fatty acid amide hydrolase by BIA 10-2474 in rat brain (2017) (10)
- Radiosynthesis, ex vivo and in vivo evaluation of [11C]preclamol as a partial dopamine D2 agonist radioligand for positron emission tomography (2006) (10)
- Decreased pallidal vesicular monoamine transporter type 2 availability in Parkinson's disease: The contribution of the nigropallidal pathway (2019) (10)
- Fatty acid amide hydrolase binding is inversely correlated with amygdalar functional connectivity: a combined positron emission tomography and magnetic resonance imaging study in healthy individuals (2021) (10)
- Labelling of monoclonal antibodies 10B, 8C, and M2A with indium-111. (1989) (9)
- Facile radiosynthesis of fluorine-18 labeled beta-blockers. Synthesis, radiolabeling, and ex vivo biodistribution of [18F]-(2S and 2R)-1-(1-fluoropropan-2-ylamino)-3-(m-tolyloxy)propan-2-ol. (2008) (9)
- Imaging of astrocytes in posttraumatic stress disorder: A PET study with the monoamine oxidase B radioligand [11C]SL25.1188 (2021) (9)
- Quantification of skeletal muscle necrosis in the lower extremities using 99Tcm pyrophosphate with single photon emission computed tomography. (1992) (9)
- Blood brain barrier permeability of [11C]loperamide in humans under normal and impaired P-glycoprotein function (2008) (9)
- Abnormal thallium kinetics in postoperative coarctation of the aorta: evidence for diffuse hypertension-induced vascular pathology. (1986) (9)
- Microglia imaging in methamphetamine use disorder: a positron emission tomography study with the 18 kDa translocator protein radioligand [F‐18]FEPPA (2020) (9)
- First demonstration of D3 occupancy in humans blockade of [C-11]-(+)-PHNO PET by ABT-925 (2008) (9)
- Synthesis and preliminary evaluation of [18F]-fluoro-(2S)-Exaprolol for imaging cerebral β-adrenergic receptors with PET (2008) (9)
- A case of apathy due to frontotemporal dementia responsive to memantine (2013) (8)
- Preliminary data indicating a connection between stress-induced prefrontal dopamine release and hippocampal TSPO expression in the psychosis spectrum (2019) (8)
- The physical performances of a single slice positron tomographic system and preliminary results in a clinical environment (1979) (8)
- Chapter 51 - Measurement of [ 11 C]Radopride Binding Using a Bolus plus Infusion Protocol (1996) (8)
- Anxiety in Parkinson’s disease: Abnormal resting activity and connectivity (2021) (7)
- The role of P-glycoprotein on blood brain barrier permeability of [11C]Loperamide in humans (2008) (7)
- A comparison of three methods to determine the radiochemical purity of 99Tcm-hexamethylpropylene amine oxime (99Tcm-HMPAO) (1989) (7)
- Influence of Nicotine Metabolism Ratio on [11C]-(+)-PHNO PET Binding in Tobacco Smokers (2018) (7)
- Synthesis and in vitro evaluation of derivatives of the β₁-adrenergic receptor antagonist HX-CH 44. (2011) (7)
- A comparison of nitroglycerin and nitroprusside: II. The effects of volume loading. (1985) (7)
- Dissecting human memory with Positron Emission Tomography (1995) (7)
- Rapid quality control of 99Tcm-sestamibi. (1992) (7)
- Differential cardiovascular and hypothalamic pituitary response to amphetamine in male pathological gamblers versus healthy controls (2015) (7)
- Compartmental analysis of the pharmacokinetics of radioiodinated monoclonal antibody B72.3 in colon cancer patients. (1993) (6)
- Effect of intracoronary nitroglycerin on myocardial blood flow and distribution in pacing-induced angina pectoris. Quantitative assessment by single-photon emission tomography. (1985) (6)
- Biodistribution and Radiation Dosimetry of the Serotonin 5-HT6 Ligand [11C]GSK215083 Determined from Human Whole-Body PET (2012) (6)
- Up-regulated dopamine D1 receptor binding can be detected in vivo following repeated SCH 23390, but not SKF 81297 or 6-hydroxydopamine, treatments. (2003) (6)
- Carbon-11 labelled cholecystokininB antagonists: radiosynthesis and evaluation in rats. (2001) (6)
- No change in dopamine D1 receptor in vivo binding in rats after sub-chronic haloperidol treatment. (2002) (6)
- Statistical Power Analysis of in Vivo Studies in Rat Brain Using PET Radiotracers 1 1Transcripts of the BRAINPET97 discussion of this chapter can be found in Section VIII. (1998) (6)
- A double-blind placebo-controlled trial of minocycline on translocator protein distribution volume in treatment-resistant major depressive disorder (2021) (6)
- PET Imaging During Subthalamic Nucleus Stimulation in PD Patients (1998) (6)
- Serotonin transporter occupancy by citalopram treatment in geriatric depression (2008) (5)
- [18F]AV‐1451 binding and postmortem pathology of CBD (2018) (5)
- The use of positron emission tomography for the investigation of changes in brain activation patterns following intensive stuttering treatment (1997) (5)
- Towards the development of new subtype-specific muscarinic receptor radiopharmaceuticals — Radiosynthesis and ex vivo biodistribution of [18F]3-(4-(2-(2-(2-fluoroethoxy)ethoxy)ethylthio)-1,2,5-thiadiazol-3-yl)-1-methyl-1,2,5,6-tetrahydropyridine (2010) (5)
- 49. What is the lowest effective dose of haloperidol? Evidence from pet studies (1996) (5)
- PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers (2020) (5)
- Validation of a method for automatic quantification of radioactivity in the globus pallidus in [11C]-(+)-PHNO PET images (2006) (5)
- Quantitation of skeletal muscle necrosis using 99Tcm-pyrophosphate with SPECT in a canine model. (1990) (4)
- O-12-8 Risperidone and the relationship between D2 receptor occupancy and plasma levels (1996) (4)
- 29-4 Role of the prefrontal cortex in human episodic memory: Lessons from PET studies (1997) (4)
- Modification of silent and exercise induced ischemia by diltiazem in stable coronary disease (1988) (4)
- Side effects profile of [11C]-(+)-PHNO in human, a dopamine D2/3 agonist ligand (2009) (4)
- A positron emission tomography study of treatment-related changes in brain activation patterns following a three-week intensive intervention program for stuttering adults. (1998) (4)
- Validation of left ventricular function parameters acquired with the non-imaging nuclear probe: comparison with tantalum marker cine-fluoroscopy. (1990) (4)
- Release your horses: Deep Brain Stimulation of the subthalamic nucleus improves motor functions at the expense of response inhibition. A H215O PET study. (2009) (4)
- Misunderstandings About How to Choose a Reference Region (2007) (3)
- The I-131 Rose Bengal Excretion Test Is Not Dead (1985) (3)
- A rapid one-step radiosynthesis of [11C]-d-threo-methylphenidate (2011) (3)
- Voxel level quantification of [11C]CURB, a radioligand for Fatty Acid Amide Hydrolase, using high resolution positron emission tomography (2018) (3)
- Absence of residual effects after physiological stimulation of the visual and motor cortex: an [15O]-H2O PET study in humans (1994) (3)
- N‐(4‐Methoxybenzyl)‐N′‐(5‐nitro‐1,3‐thiazol‐2‐yl)urea (AR‐A014418) (2007) (3)
- Further progress on a remarkably simple captive solvent method for [11C]-methylations (2001) (3)
- Increased vesicular monoamine transporter binding during early abstinence from chronic methamphetamine abuse: Preliminary PET/(+)[11C]DTBZ findings (2008) (3)
- Scintigraphic Findings in Congenital Lipodystrophy (1989) (3)
- Kinetics of [11C]-(+)-PHNO binding in the globus pallidus (2008) (3)
- 471 'Typical' vs. 'Atypical': Lessons from pet studies of 5-HT2 and D2 occupancy of antipsychotics (1997) (3)
- 58. Altered response to intravenous d-fenfluramine during depression using [15O]-PET (1996) (3)
- Analysis of Variance in Neuroreceptor Ligand Imaging Studies (2011) (3)
- Imaging of the Head, Neck, Spine, and Brain (2019) (3)
- Prospective assessment of cardiac function in patients with Kaposi's sarcoma and the acquired immune deficiency syndrome. (1991) (3)
- β-Amyloid Imaging In Vivo and Its Possible Implications for Alzheimer’s Disease (2004) (2)
- Nuclear Medicine in Urology and Nephrology. 2d ed (1987) (2)
- Whole-Body Distribution and Radiation Dosimetry of 11C-(+)-PHNO, a D2/3 Agonist Ligand (2009) (2)
- Prefrontal cortical dopamine release in clinical high risk for psychosis during a cognitive task: a [11C]FLB457 positron emission tomography study (2019) (2)
- STRESS-INDUCED DOPAMINE RELEASE IN SUBJECTS AT CLINICAL HIGH RISK FOR PSYCHOSIS AND IN ANTIPSYCHOTIC NAIVE PATIENTS WITH PSYCHOSIS: A [ 11 C]-(+)-PHNO PET STUDY (2010) (2)
- Parametric modeling of [11C]harmine acquired on the HRRT PET (2009) (2)
- PV1 Whole-Body Radiation Dosimetry of 11 C-Carbonyl-URB694: A PET Tracer for Fatty Acid Amide Hydrolase (2014) (2)
- Prefrontal D2‐receptor stimulation mediates flexible adaptation of economic preference hierarchies (2013) (2)
- 51. Investigating Endocannabinoid Mechanisms in Posttraumatic Stress Disorder: Neuroimaging Studies With the Novel Fatty Acid Amide Hydrolase Probe, [11C]CURB (2018) (2)
- Validation of cardiac single photon emission tomography of labeled intracoronary microspheres as a method to measure changes in distribution of coronary blood flow. (1986) (2)
- O-12-3 Relationship between D2 receptor occupancy and plasma haloperidol: A pet study (1996) (2)
- Cognitive Neuroscience and Neuropsychology (1997) (2)
- Regional cerebral blood flow in bipolar disorder measured with PET: trait effects at rest and after mood induction (2002) (2)
- 55. Reliability of a non-invasive [11C]-Raclopride scan to measure D2-Dopamine receptors (1996) (2)
- Positron emission tomography quantification of [11C]-(+)-PHNO binding to the dopamine D2/D3 receptors in the human brain (2006) (2)
- La tomographie par emission de positrons: Son potentiel dans les etudes quantitatives: Positron Emission Tomography, Possibilities in Quantitative Studies (1980) (1)
- A one-step radiosynthesis of [11C]methylphenidate (2010) (1)
- Image subtractions do not always add up: The interaction between semantic processing and response modes (1996) (1)
- [11C]-URB694 for FAAH PET imaging: A novel radiotracer for a new target (2010) (1)
- Thalamic Stimulation Activates The Anterior Cingulate Cortex in Chronic Pain Patients: A PET Study (1998) (1)
- CHAPTER 53 – Kinetic Modeling: Achieving Computer Platform Independence with Java (1998) (1)
- The influence of conditioned stimuli on [11C]-(+)-PHNO PET binding in tobacco smokers after a one week abstinence (2021) (1)
- P.1.e.007 Elevated prefrontal cortex monoamine oxidase-A binding in major depressive disorder and comorbid borderline personality disorder (2012) (1)
- Antipsychotic-induced D2-receptor upregulation — differential effect of continuous versus transient D2-receptor blockade (2003) (1)
- Transient biventricular dysfunction following coronary bypass surgery with potassium cardioplegia. (1987) (1)
- P.1.e.010 Understanding postpartum blues: a time course of MAO-A levels in the living human brain during the postpartum period (2009) (1)
- Synthesis of R‐[N‐methyl‐13C]SKF 82957 from [13C]methyl iodide and [13C]methyl triflate (2000) (1)
- Localization of the functional effects of clonidine by PET (1995) (1)
- 619. Brain Levels of Fatty Acid Amide Hydrolase Are Not Altered in Overweight Healthy Individuals: A Pilot PET Study with [11C]CURB (2017) (1)
- P.3.b.037 Neuroinflammation in schizophrenia: a PET study with [18F]-FEPPA (2013) (1)
- S169. MICROGLIAL ACTIVATION AND MORPHOLOGICAL BRAIN ALTERATIONS IN PSYCHOSIS AND PSYCHOSIS RISK (2018) (1)
- A Human Liver Model of Metabolism as a Tool in the Identification of Potential PET Radiotracers 1 1Transcripts of the BRAINPET97 discussion of this chapter can be found in Section VIII. (1998) (1)
- Increase in dopamine D2 receptor binding following long-term treatment with neuroleptics in humans (2000) (1)
- O3-03-07 [11C]SB-13 PET: a valid alternative for β-amyloid imaging in vivo? (2004) (1)
- 286. 5-HT2A receptors in depression pre/post paroxetine (2000) (1)
- Monoamine oxidase A (MAO-A)binding in prefrontal and anterior cingulate cortex in postpartum depression (2011) (1)
- 26.2 CORTICAL STRESS REGULATION IS DISRUPTED IN SCHIZOPHRENIA BUT NOT IN CLINICAL HIGH-RISK FOR PSYCHOSIS (2018) (1)
- Evaluation of a small library of carbamates and ureas, including PF-04457845, as potential imaging agents for fatty acid amide hydrolase (FAAH) (2012) (1)
- Amyloid imaging with [11C]SB-13 PET: A test-retest reliability study (2010) (1)
- Theta burst stimulation of dorsolateral prefrontal cortex reveals hemispheric asymmetry in striatal dopamine release during set-shifting task in human (2009) (1)
- 117.3 Imaging Microglial Activation in Clinical High Risk for Psychosis and Untreated First-Episode Psychosis: A PET StudyW [18F]FEPPA (2017) (1)
- S265. Endocannabinoid Metabolism and Alcohol Consumption in Youth: A PET Study With the Fatty Acid Amide Hydrolase Radioligand [11C]CURB (2018) (1)
- The D2-agonist radiotracer [11C]-(+)-PHNO shows a marked increase in sensitivity to amphetamine challenges when compared to [11C]raclopride in the cat brain (2005) (1)
- Localization of the functional effects of apomorphine—A pet study in humans (1994) (1)
- Investigation of Irreversible Reference Tissue Models for Parametric Imaging (1998) (1)
- Binding Potential of [18F]Setoperone: Reproducibility of Measures by the Simplified Reference Tissue Method (1998) (1)
- Effect of intracoronary nifedipine on coronary bloodflow and myocardial metabolism during pacing-induced ischemia. (1990) (1)
- Functional associations among cortical regions during processing of object identity and spatial location in episodic long-term memory (1996) (1)
- Monoamine oxidase A in postpartum depression (2008) (0)
- EXAGGERATED DOPAMINE RELEASE IN IMMIGRANTS DURING SOCIAL STRESS: A RISK MECHANISM FOR PSYCHOSIS (2014) (0)
- F134. Association of Neuroinflammation With Duration of Untreated Major Depressive Disorder (2019) (0)
- Modulation of neuronal activity by a serotonergic agonist: A pet study in humans (1994) (0)
- Validation of an Automated [15O] H20 injection System for PET Activation Studies. (1998) (0)
- Serotonin transporter occupancy of high dose serotonin reuptake inhibitor antidepressants in major depressive disorder (2008) (0)
- Revisiting [18F]FHMP for imaging MAO-B (2010) (0)
- Comparison of the tumor and inflammation uptake of [18F]-deoxy-1-fluoro-scyllo-inositol and [18F]-FDG in athymic mice bearing human breast cancer xenografts (2010) (0)
- [11C]-Harmine PET of monoamine oxidase A binding in early postpartum (2009) (0)
- PET Strategies for the Investigation or Neuropsychiatric Diseases (1994) (0)
- 67. Intravenous d-fenfluramine challenge with [15O] H2O pet in panic disorder (1998) (0)
- In vivo brain endocannabinoid metabolism is related to hippocampus glutamate and structure – a multimodal imaging study with PET, 1H-MRS, and MRI (2022) (0)
- P1.105 rCBF changes associated with pathological gambling in Parkinson's disease: a H215O PET study (2009) (0)
- 138. Stress-Induced Prefrontocortical Dopamine Response is Altered in Subjects at Clinical High Risk for Psychosis Using Cannabis (2019) (0)
- P.1.e.005 Neural correlates of postpartum depression: elevated monoamine oxidase A (MAO-A) binding in prefrontal and anterior cingulate cortex (2012) (0)
- Neurochemical aspects of porstpartum mood changes: a time course of monoamine oxidase a levels during the postpartum period (2009) (0)
- P.1.i.023 Increased translocator protein distribution volume, a marker of microglial activation, in the brain during major depressive episodes (2014) (0)
- N-[11/13C]Methylation versus O-[11/13C]methylation using [11/13C]methyl iodide or [11/13C]methyl triflate in molecules containing both amino and phenol/catechol groups (2001) (0)
- IMAGING NEUROINFLAMMATION IN AMNESTIC MILD COGNITIVE IMPAIRMENT (AMCI) USING A NOVEL PET RADIOLIGAND: [18F]-FEPPA (2016) (0)
- New detection configuration for low activity levels of PET tracers during the analysis of plasma samples. (2019) (0)
- The Interaction Between Neuroinflammation and β-Amyloid in Cognitive Decline in Parkinson’s Disease (2019) (0)
- Amyloid imaging with [11C]SB-13 PET in patients with mild Alzheimer's disease: A test-retest reliability study of distribution volume ratio estimates (2011) (0)
- A Comparison of Nitroglycerin and Nitroprusside: I. Treatment of Postoperative Hypertension (1985) (0)
- 56. A pet study of the clonidine challenge test in depressed women (1998) (0)
- Evaluation of [11C]-(+)-PHNO as an agonist radiotracer for imaging high-affinity dopamine D2 receptors (2005) (0)
- Imaging oxidative stress in brains of chronic methamphetamine users: A combined 1H-magnetic resonance spectroscopy and peripheral blood biomarker study (2023) (0)
- F37. Is There Astrocyte Pathology in PTSD? Preliminary Findings of a PET Study With the Monoamine Oxidase B Radioligand [11C]SL25.1188 (2019) (0)
- Amyloid imaging with [11C]SB-13 PET in patients with mild Alzheimer's disease: A test-retest reliability study of distribution volume ratio estimates (2011) (0)
- LBP‐005: Efficacy and safety of Sofosbuvir/Velpatasvir for the treatment of treatment‐naïve, non‐cirrhotic patients with chronic hepatitis C genotype 3 infection: integrated analysis of three phase 3 clinical trials (2018) (0)
- ASSOCIATION BETWEEN AV-1451 PET TAU SUVR AND NEUROPSYCHOLOGICAL ASSESSMENTS IN PATIENTS WITH PROGRESSIVE SUPRANUCLEAR PALSY (PSP) (2018) (0)
- and when General and specific brain regions involved in encoding and retrieval of events: What, where, (2007) (0)
- Amyloid Imaging with [11C]SB-13 PET: A Test-Retest Reliability Study (2010) (0)
- 4-Bromo-8-methoxyquinoline (2008) (0)
- Investigating the use of plasma pTau181 in retired contact sports athletes (2022) (0)
- Serotonin Transporter Concentration is Decreased in Cerebral Cortex but not in Striatum of Chronic MDMA (ecstasy) Users (2009) (0)
- Phenotype differences between corticobasal syndrome and progressive supranuclear palsy with and without Alzheimer’s disease biomarkers (2020) (0)
- P.1.i.048 Seasonal variation in serotonin transporter binding in seasonal affective disorder and health: a [11C]DASB positron emission tomography study (2015) (0)
- PIB-Positive PET in Individuals with Early- but Not Late-Onset Frontotemporal Dementia (P6.326) (2014) (0)
- Association between Fatty Acid Amide Hydrolase and Alcohol Response Phenotypes: A PET Imaging Study with [11C]CURB in Heavy-drinking Youth (2022) (0)
- PET and behavioral responses to IV d-fenfluramine in humans (1995) (0)
- Fatty Acid Amide Hydrolase and Threat Related Amygdala Activity: A Combined Positron Emission Tomography and Magnetic Resonance Imaging Study (2020) (0)
- Parkinson's disease, impulse control disorder and the D3 dopamine receptor system: Preliminary PET imaging studies with [11C](+)PHNO comparison with [11C]racloride (2010) (0)
- PET Study of Functional Dissociation or Episodic and Semantic Memory (1994) (0)
- Imaging changes associated with cognitive abnormalities in Parkinson’s disease (2014) (0)
- General andspecific brainregions involved inencoding and retrieval ofevents: What,where,andwhen (1996) (0)
- A new approach for an HPLC metabolite radiation detection system which increases sensitivity and optimizes data acquisition (2006) (0)
- Cortical Dopaminergic Deficiency in Schizophrenia While Performing a Cognitive Task (2015) (0)
- Left prefrontal dysfunction in Schizophrenia using cognitive activations-beyond the Wisconsin card sort task (1995) (0)
- Microglial activation in Parkinson’s disease using [18F]-FEPPA (2017) (0)
- Investigating Brain Monoamine Oxidase B Status in Alcohol Use Disorder With the Positron Emission Tomography (PET) Tracer [C-11]SL25.1188 (2020) (0)
- INTEROBSERVER RELIABILITY IN QUANTITATIVE PHASE ANALYSIS OF RESTING GATED EQUILIBRIUM STUDIES (1982) (0)
- COMPARATIVE PHARMACOKINETICS, RADIOIM-AGING AND BIODISTRIBUTION PROPERTIES OF MONOCLONAL ANTIBODY CC83 LABELLED WITH Tc-99m OR I-123 (1993) (0)
- 58. The receptor occupancy of olanzapine assessed with pet: Theoretical and clinical implications (1998) (0)
- Development of New PET radiopharmaceuticals for imaging monoamine oxidase-B (2010) (0)
- Recent advances towards imaging cerebral β-adrenergic receptors with PET (2008) (0)
- Correction to: Elevated fatty acid amide hydrolase in the prefrontal cortex of borderline personality disorder: a [11C] CURB positron emission tomography study (2021) (0)
- Effects of d -amphetamine on binding of the new D2/3 receptor agonist radioligand [11C]-(+)-PHNO in humans (2006) (0)
- Sensitivity of voxel based comparisons for PET ligands with SPM (2001) (0)
- Prefrontal cortex MAO-A binding in cigarette smokers under acute abstinence (2009) (0)
- Network Patterns of Beta-Amyloid Deposition in Parkinson’s Disease (2019) (0)
- Applications of Radiotracer Imaging Poster Abstracts (2012) (0)
- 10-2 Does loxapine plus cyproheptadine make clozapine: Evidence from PET imaging (1997) (0)
- New classes of fluorine-18 labelled radiotracers for imaging dementia (2009) (0)
- Cardiac Nuclear Medicine (1987) (0)
- Serotonin transporter occupancy of high dose antidepressants in treatment refractory depression: An [11C] DASB positron emission tomography (PET) study (2009) (0)
- Human dosimetry for the 5-HT6 PET ligand [11C]GSK215083 (2009) (0)
- A MODEL TO DESCRIBE THE PHARMACOKINETICS OF I-131 B72.3 MONOCLONAL ANTIBODY IN COLON CANCER PATIENTS (1991) (0)
- PET imaging of dopamine D1 and D2 receptors in patients treated with clozapine, olanzapine, quetiapine, or risperidone (2003) (0)
- [C-11]PHNO and [C-11]racloride PET imaging of dopamine receptors in drug-naive Parkinson's disease (2008) (0)
- ACNP 56th Annual Meeting: Poster Session III, December 6, 2017 (2017) (0)
- [18F]AV-1451 binding to neuromelanin in the substantia nigra in PD and PSP (2017) (0)
- Investigating TSPO levels in occupation-related posttraumatic stress disorder (2023) (0)
- GreaterMonoamine Oxidase A Binding in Perimenopausal Age asMeasuredWith Carbon 11 – Labeled Harmine Positron Emission Tomography (2014) (0)
- O-12-1 Is loxapine an ‘atypical’ antipsychotic: A pet study of the in vivo 5-HT2 and D2 occupancy (1996) (0)
- P.6.a.002 Monoamine oxidase A binding during acute alcohol withdrawal: a [C]-harmine PET study (2012) (0)
- MAO-A: A core neurochemical imaging biomarker for postpartum depression (PPD) and populations at risk for PPD (2014) (0)
- Monoamine oxidase A in the postpartum period (2008) (0)
- Efficient synthesis of [18F]-{beta}-blockers: [18F]-S-fluoro-toliprolol and exaprolol (2008) (0)
- Endocannabinoid Metabolism in Posttraumatic Stress Disorder: Results From a Neuroimaging Study With the Novel Fatty Acid Amide Hydrolase Probe, [C-11] Curb (2020) (0)
- S164. “AT-RISK MENTAL STATES” PROGRAM IN LAUSANNE: INFLUENCE OF RECRUITMENT STRATEGIES ON THE RATE OF FALSE POSITIVES (2018) (0)
- Methode de synthese de composes radiomarques (2001) (0)
- Review of the axillary lymph node dissection for breast cancer in an ambulatory setting (1999) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Sylvain Houle?
Sylvain Houle is affiliated with the following schools:
